📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. (2014)

First Author: Fucito LM

Attributed to: The UK Centre for Tobacco Control Studies funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ntr/ntu087

PubMed Identifier: 24919399

Publication URI: http://europepmc.org/abstract/MED/24919399

Type: Journal Article/Review

Volume: 16

Parent Publication: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Issue: 7

ISSN: 1462-2203